Piotr Skałba

ORCID: 0000-0001-5775-7846
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian function and disorders
  • Neonatal Respiratory Health Research
  • Pregnancy and preeclampsia studies
  • Reproductive Biology and Fertility
  • Hormonal and reproductive studies
  • Estrogen and related hormone effects
  • Sexual Differentiation and Disorders
  • Uterine Myomas and Treatments
  • Reproductive System and Pregnancy
  • Congenital Diaphragmatic Hernia Studies
  • Growth Hormone and Insulin-like Growth Factors
  • Gynecological conditions and treatments
  • Regulation of Appetite and Obesity
  • Metabolism and Genetic Disorders
  • Nutrition and Health Studies
  • Birth, Development, and Health
  • Ectopic Pregnancy Diagnosis and Management
  • Preterm Birth and Chorioamnionitis
  • Iron Metabolism and Disorders
  • Lipid metabolism and disorders
  • Urological Disorders and Treatments
  • Gestational Trophoblastic Disease Studies
  • Adipose Tissue and Metabolism
  • Apelin-related biomedical research
  • Arctic and Antarctic ice dynamics

Medical University of Silesia
2003-2014

Górnośląskie Centrum Medyczne
1993-2013

Abstract Objective The aim of the study was to analyse relationships between plasma apelin‐36 and apelin‐12 levels, nutritional status, insulin resistance hormonal disturbances, as well adiponectin, leptin resistin concentrations in PCOS women. Study design patients measurements A cross‐sectional involving 87 (48 obese) 67 non‐ women (36 obese). Anthropometric parameters body composition were determined. Serum glucose, androgens, FSH , LH SHBG insulin, apelin‐36, apelin‐12, measured fasting...

10.1111/cen.12120 article EN Clinical Endocrinology 2012-12-01

It is suggested that disturbed adipokines release plays a role in PCOS pathogenesis. The aim of this study was to assess plasma levels omentin and adiponectin as well the ratio, markers adipose tissue dysfunction relation hormonal or metabolic changes PCOS.A cross-sectional involved 87 (48 obese) 72 non-PCOS women (41 obese). Anthropometric parameters body composition were determined, serum glucose, hormones, omentin-1 measured.The level similar groups, but, both, significantly lower obese...

10.1111/cen.12381 article EN Clinical Endocrinology 2013-12-09

The aim of the study was to analyse relationship between nutritional status, selected adipokines and plasma anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).A prospective, cross-sectional study, involving 87 PCOS (48 obese) 67 non-PCOS (36 obese). Anthropometric parameters were measured, body composition determined by bioimpedance method. Fasting serum glucose, androgens, FSH, LH, SHBG, insulin, AMH, apelin-36, adiponectin, leptin omentin-1 measured.Plasma...

10.1111/cen.12687 article EN Clinical Endocrinology 2014-12-01

Anovulatory cycles and endometriosis are the main causes of female infertility. The most frequently anovulatory related to polycystic ovary syndrome (PCOS) commonly associated with obesity hormonal disturbances in course obesity. Recently published studies revealed that infertility affects about one six couples during their lifetime is more frequent obese. Obesity also male erectile dysfunction, lower semen quality. Any these above mentioned disorder important risk factor psychological poor...

10.1155/2012/236217 article EN cc-by International Journal of Endocrinology 2012-01-01

Androgens influence the growth of terminal hair. The dermal papilla contains androgen receptors and enzymes 5-alpha-reductase types 1 2. Both these convert testosterone to more active androgen, 5-alpha-dihydrotestosterone. male distribution pattern hair in females is termed hirsutism. It most common among women with hyperandrogenism; however, it may also affect patients normal levels (idiopathic hirsutism).The aim this study was assess expression 2 mRNA papillae from lower abdominal skin...

10.1111/j.1365-2230.2006.02146.x article EN Clinical and Experimental Dermatology 2006-05-22

During fetal life, placental tissue represents an additional source of leptin for the mother and conceptus. It has been suggested that feto-placental production may be involved in growth regulation. The aim this study was to examine correlation between mRNA expression placenta concentrations cord blood. A total 30 healthy, pregnant women who gave birth healthy neonates were included study. Maternal blood (obtained from cubital vein) umbilical drawn immediately after birth. Serum...

10.1080/gye.17.4.311.316 article EN Gynecological Endocrinology 2003-01-01

To check whether currently used combined oral contraceptives (COCs) containing ethinylestradiol (EE) affect the liver microsomal metabolism.(13)C-methacetin breath test ((13)C-MBT) - a sensitive non-invasive probe of cytochrome P-450 1A2 activity was performed in 15 women on day 14, 15, 16, 17 or 18 intake their COC (containing EE), and between 1 5 during withdrawal bleeding, as well nine not using hormonal contraception luteal phase cycle (between 17th 23rd day), menstruation.The maximum...

10.3109/13625187.2013.785515 article EN The European Journal of Contraception & Reproductive Health Care 2013-05-06

A combination of the congenital abnormalities, Müllerian duct aplasia, renal and cervicothoracic somite dysplasia, is defined as MURCS association. Various genetic defects have been described in association so far, yet unambiguous molecular basis these disorders has not established. We report case an 18-year-old woman who presented with primary amenorrhea, right kidney, Arnold-Chiari malformation, Klippel-Feil syndrome. In addition, patient showed following unusual features: ovarian Skenes...

10.1155/2013/105052 article EN cc-by Case Reports in Genetics 2013-01-01

Objectives To examine liver mitochondrial function in women using combined oral contraceptives (COCs) containing ethinylestradiol.

10.3109/13625187.2013.819847 article EN The European Journal of Contraception & Reproductive Health Care 2013-08-12

CLINICAL PRACTICE QUESTIONS AND ANSWERS Menopause in questions and answers 1 who have given their informed consent to start the therapy after reviewing its risks benefits with physician.The results of studies do not support prevention cardiovascular disease as an indication HRT, even early postmenopausal period.Nevertheless, HRT may be highest if is started earlier, optimally perimenopausal period.HRT should women over 60 years age, it was shown associated higher risk fewer benefits.Experts...

10.20452/pamw.3671 article EN Polskie Archiwum Medycyny Wewnętrznej 2016-11-30
Coming Soon ...